The State Board of Health hereby designates the following as a heritable disease subject to testing, reporting and notification requirements herein below specified. Phenylketonuria, hypothyroidism, galactosemia, congenital adrenal hyperplasia, hearing loss, hemoglobinopathy, biotinidase deficiency, cystic fibrosis, aminoacidopathies, fatty acid oxidation disorders, organic acidurias and acidemias, CCHD, SCID, SMA, X-ALD, lysosomal storage disorders, and other heritable disorders.

Author: P. Scott Harris, M.D., Thomas M. Miller, M.D.; William J. Callan, Ph.D.; Sharon P. Massingale, Ph.D., Aretha M. Williams, Ph.D., Lucinda G. Ashley, R.N. – B.C., Rachael N. Montgomery, B.S.N., R.N.

Statutory Authority: Code of Ala. 1975, §22-2-2, 22-20-3.

History: Filed December 21, 1987. Amended: Filed September 21, 1992; effective October 26, 1992. Repealed and New Rule: Filed December 17, 2003; effective January 21, 2004. Amended: Filed December 17, 2007; effective January 21, 2008. Amended: Filed May 17, 2013; effective June 21, 2013. Amended: Filed January 19, 2017; effective March 5, 2017. Amended: Published December 30, 2021; effective February 13, 2022.